Pharmaceutical enterprises or "preparation" transition orgasm
Release time: 2010-11-10 & nbsp & nbsp & nbsp Source:
Reporter learned from the authoritative person，my country's relevant departments have recently introduced support policies for encouraging preparation innovation。The "Twelfth Five -Year Plan" plan that is about to be introduced will also "upgrade" the pharmaceutical industry as the point，Among them, it mainly includes drug innovation upgrades and preparation upgrades。
Mei Xingguo, Director of the Pharmacy Teaching and Research Office of the Chinese Academy of Military Medical Sciences, said，At the time of the current era of global drug research and development,，my country's preparation innovation business urgently needs policy support from research and development to product pricing，and many domestic and homogeneous competition raw products may also take this as an opportunity，Originals of the transition from the transition from the drug -oriented agent from the raw material，The reshuffle in the ray and drug industry will accelerate。
"Heavy raw materials lightweight agent" needs to be changed urgently
In recent years，Compared with the raw materials business，my country's pharmaceutical industry has developed much attention to preparations for many years，The level of preparation technology lags behind abroad，formed my country's "Export Materials Drug、Import Preparation "trade status。
A large amount of materials produced in my country are relatively low in technology content，gross profit margin is also repeatedly compressed due to homogeneous competition，and a preparation of a higher gross profit margin stake sports betting appneed stake online sports bettingto be imported from abroad，This also caused the profit level of my country's pharmaceutical industry to be significantly lower than foreign。
At present, the study of dosage forms in my country has greatly lagged behind Western developed countries。U.S. Pharmacopoeia 90 version is 31 types of dosage，British Pharmacopoeia 36 kinds，Japanese Pharmacy (12th edition) also collects 27 kinds，and Chinese Pharmacopoeia 90 version only included 12 species。Usually a foreign ingredients have more than 10 preparation types，and my country is about 3 types，Most of them are imported varieties。
Mei Xingguo said，The reasons for the delay in industrialization of our innovative preparations，In addition to the insufficient support for preparation innovation in pharmaceutical policy，Chinese pharmaceutical companies have not fully understood the potential commercial value and long -term interests of preparation development，Failure to make sufficient industrial investment。
Actually，Dositive research is much more effective in the development of the pharmaceutical industry than raw materials。Data display，The core of the pharmaceutical industry industry chain is medicine intermediate、Materials and preparations，These three links account for 5%in the entire pharmaceutical industry, respectively.、10%、80%。So，my country's encouragement of innovative preparations is imperative。
It is understood，At present, the biggest difference between domestic drugs and imported drugs in my country is the drug process and dosage form，The difference in actual raw materials is not large。Luo Yilong, deputy general manager of Beijing Pharmaceutical Group, believes，Dested，The research and development of innovative preparations is particularly suitable for Chinese pharmaceutical companies。For example，Perform dosage reforms on the medicines that have been listed，It is easy to develop it、Control slow -release agent with higher added value，A effective replenishment for the development of new drugs。
In addition，For medicines that are about to surpass the patent protection period，A preparation of the drug can make the drug re -obtain the market and sales。Drugs with a large number of glorious sales in the world are facing the problem of patent expiration，Take this opportunity to strengthen encouraging preparation stake online sports bettinginnovation，It is likely to bring My stake betting appnew vitality to my country's pharmaceutical industry。
Preparation innovation is more feasible
Whether it is the "Decision of the State Council on Accelerating Cultivation and Development Strategic Emerging Industry" that the State Council has recently disclosed，Still the "Twelfth Five -Year Plan" plan for biomedicine，All will improve the ability of the pharmaceutical industry to innovate、Promoting the development of innovative drugs to the first position。
But，The research and development of innovative drugs itself encountered a staged dilemma。It is understood，In recent years, innovative drug research and development of the global pharmaceutical industry has faced the embarrassment of "difficulty"。In recent years，The cycle of developing a new drug abroad is continuously increased，Development risks are getting greater and greater，More and more capital investment，The chance of success is getting smaller and smaller。In the short term，It is difficult for Chinese pharmaceutical companies to compete with international pharmaceutical giants in this regard。
It is difficult to pinching it in the development of innovative drugs，This means that my country must find more feasible ways to quickly improve the competitiveness of my country's pharmaceutical industry。
Mei Xingguo said，Innovative preparations have a short R & D cycle、Investment less、Low risk，Effective、Safety guarantee and other advantages，As early as ten years ago，The development of the pharmaceutical industry in the Western country clearly reflects the development strategy of paying attention to preparations，It can be said now，Global pharmaceutical research and development has entered the era of preparation innovation。
Statistics display of US pharmaceutical research and development institutions，Developing a new chemical medicine average cost 5-1 billion U.S. dollars，Live 10-12 years，and developing an innovative preparation only cost $ 50 million，Average only 3-4 years。
So，Many international large pharmaceutical companies have begun to turn their attention to the development of new products for existing products。In addition to higher cost performance，Many existing chemicals、Biopharmaceuticals due to low solubility、Poor stability、Difficulty of delivery difficulties，It is difficult to play the best clinical efficacy，stake sports betting appIf Stake Sports Bettingthe traditional dosage type upgrade of the medicine is used through preparation innovation，can avoid the above shortcomings，Significant improvement of drug efficacy。
The transformation of pharmaceutical companies is quietly first
Mei Xingguo said，During the "Eleventh Five -Year Plan" period，Policy's support for preparation innovation is obviously insufficient，For example, the establishment of new drug research and development major special special、When providing funding support for the development of new drugs，Preparation innovation is not included; in the pricing of the price department to the medical insurance directory and the basic drug directory，Innovative preparations are also difficult to enjoy the autonomous pricing rights similar to exclusive Chinese medicine。
On the one hand, insufficient research and development support，On the other hand is insufficient terminal pricing support，Make the enthusiasm of pharmaceutical companies in preparation innovation.。Pharmaceutical companies look forward to these two aspects of policy status.。
Analysts said，For my country's pharmaceutical listed companies，Although each enterprise has its own advantages，But due to the lack of independent innovation ability，Overall the homogeneity competition of pharmaceutical preparations is serious，The innovation of modern traditional Chinese medicine preparations is only in the attempt。So，Only the state increases policy preferential strength、Scientific research projects and fund support，can inspire the enthusiasm of the innovative preparation of pharmaceutical companies。
Current，Many pharmaceutical companies, including Hyeraga Pharmaceutical (600267), have begun to extend downstream consciously，The business transformation of the "from raw medicine to preparation"，and strive to export preparation products to the international high -end market。Analysts of Zhongjin Company said，Haizheng Pharmaceutical is currently in a critical period of transformation，In the early stage of the company of the company's preparation European exports obtained certification，Explain that the company’s strategic execution is valid。
Analysts' comments on Meiluo Pharmaceutical (600297) display，The main growth point of the company comes from the domestic preparation business and export of preparations，It is expected to be concentrated in the next two years。stake online sports bettingDomestic preparations，My stake betting appThe company's exclusive variety of wounded skeletons is expected to measure after entering the basic drug directory。
Shuanglu Pharmaceutical (002038) Actively develop and layout overseas markets based on the domestic market，The export of raw materials and preparations has been submitted to more than ten countries for registration，More than ten varieties have been registered and approved by relevant state authorities。
Jingxin Pharmaceutical (002020) due to the implementation of raw materials、Integrated preparation，The company's cardiovascular products have maintained a gross profit level of about 70%，In the future, there will be a variety of categories of categories in the company.，All raw material preparations will be integrated。Analysts introduced，With the company's early sales market for the sales market of Xinjiedin，The market sales of other Jetine products of the company are optimistic。
